Delivery Order SPE2DB22D3501-SPE2DB24FVL44
Award Date
4/26/24
Potential Completion Date
4/29/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,174.42 firm fixed-price delivery order is for the supply of Ropivacaine 0.2% 400 mg/200 ml medication, with a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary...
This contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. The $5,997.77 firm-fixed price delivery order has a completion date of November 20, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Ropivacaine 0.2% 400 mg/200 ml injections. The contract, valued at $9,396.54, is a firm fixed-price delivery order with an ultimate completion date of October 17, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant Indefinite...
This federal contract award is for the delivery of Ropivacaine 0.2% 400 mg/200 ml medication, valued at $4,820.26, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,513.30, is for the delivery of Ropivacaine 0.2% 400 mg/200 ml injectable medication. It is a firm fixed-price delivery order contract with a period of performance through July 2024. This contract award is not designated as a set-aside and represents open competition. AmerisourceBergen also holds a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,619.28, is for the delivery of 4567763133 - Ropivacaine 0.2% 400 mg/200 ml 200 ml. The contract is a firm fixed-price delivery order with an ultimate completion date of April 2, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,730.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4565221300 - Ropivacaine 0.2% 200 mg/100 ml, a pharmaceutical product, to support military treatment facilities and programs. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and does not have a set-aside designation. Amerisourcebergen, as a major...
This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0YJF, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $3,773.42 for the supply of 400 mg/200 mL of the pharmaceutical product Ropivacaine 0.2%. The contract has no set-aside designation, indicating open competition. It is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $5,002.00, is a delivery order for the supply of 400 mg/200 mL of Ropivacaine 0.2% solution. The award has a ceiling value of $5,002.00 and a completion date of February 13, 2024. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,451.86, is for the delivery of 400 mg/200 mL of Ropivacaine 0.2% solution. It is a firm fixed-price delivery order contract with a completion date of January 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...